CYTEK BIOSCIENCES, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $73.8M | $65.7M | $90.9M | $93.3M | $75.5M | $95.3M | $98.7M | $162.3M |
| Accounts Receivable | $49.7M | $51.9M | $62.5M | $56.6M | $56.2M | $55.0M | $60.6M | $52.6M |
| Inventory | $52.3M | $49.8M | $48.4M | $51.6M | $49.5M | $45.3M | $43.9M | $46.8M |
| Total Current Assets | $377.9M | $379.3M | $392.0M | $388.5M | $382.8M | $380.5M | $396.4M | $390.2M |
| Property, Plant & Equipment | $20.8M | $20.5M | $18.0M | $18.0M | $18.4M | $17.8M | $18.0M | $18.5M |
| Goodwill | $16.7M | $16.7M | $16.7M | $16.7M | $16.7M | $16.7M | $16.7M | $16.2M |
| Intangible Assets (Excl. Goodwill) | $14.9M | $15.7M | $16.8M | $17.7M | $18.6M | $19.4M | $20.1M | $20.5M |
| Total Assets | $446.9M | $449.1M | $461.5M | $494.9M | $493.3M | $482.6M | $499.5M | $491.2M |
| Liabilities | ||||||||
| Accounts Payable | $8.4M | $6.7M | $6.4M | $7.6M | $6.9M | $6.2M | $5.5M | $5.4M |
| Total Current Liabilities | $84.3M | $80.9M | $77.8M | $75.2M | $73.3M | $67.7M | $67.7M | $62.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $125.0M | $121.5M | $119.8M | $116.3M | $115.8M | $103.0M | $103.8M | $105.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-132.8M | $-120.6M | $-101.7M | $-57.7M | $-52.2M | $-46.6M | $-35.2M | $-44.8M |
| Total Stockholders' Equity | $322.0M | $327.6M | $341.7M | $378.6M | $377.6M | $379.6M | $395.7M | $385.5M |